Member Info for zebbo

are increasing, lots of more influential people starting to invest / stake build. All bodes well and should see us push through £1 in fairly short order

An update to start with. ESL has been very busy (Christmas busy), cost should be down due to fuel etc.

Mcap around 30m, 80m was offered just just a few short months ago, so clear value gap. Lets hope the accounts are ok :-)

This therapeutics are not as widely understood as the C-19 test stock. But their day is coming quickly. Vaccine is way off and it appears that there is little to no immunity once you have had C-19. This will put therapeutics under the spotlight

Agree, this is another one of those stocks that has ended up being miss priced and a great opportunity.

I am still adding at these levels, but only in 50k chunks. Filtering so C-19 related profits this way

Worrying indeed, as it mutates etc. I'm starting to look at some of the therapeutic plays such as DDDD. Think these will have a lot bigger role to play. Likelihood is that you dont build antibodies against C-19

@themuir01 DDDD...too big, its only £60M mcap

Think hot money is chasing covid stocks, however many getting past their biggest rises IMHO. Traders will soon be chasing this North + news cannot be far away

I'm in here big time, but moved a little into DDDD like AVCT, its a quality play that has not been hyped and covers therapy as opposed to test, making sure I get all bases covered. Again has multiple bagging potential

Why would they do that, they have just said all is well in the Ops update!!

Just picked up my first 25k tranche of dddd, whilst starting due dil. Not the most intelligent approach, but got carried away

Any pointers to further my knowledge, or point to any urls that may help, thanks in advance

What will be the end game for ESL and when will it come?

In SP, looks totally washed out at these levels , so picked up another 100k this AM

Now strengthening with conviction

That may be my buy, looking to build a reasonable stake over the coming weeks and started with 500k

and sounding very upbeat for the start of trade tomorrow, lots more to come for all the main players

Delusional....really
antibodies currently dominate markets worth in excess of US $100bn. Daewoong’s willingness to now formally engage with Avacta is not only a major endorsement of the Affimer technology, but also highlights Big Pharma’s determination to invest in such giant opportunity

people chasing dreams with no research. I'm fully researched and there is only one outright winner AVCT...IMO

Could we take that out tomorrow....who knows, but the re rate continues unabated.

News due early next week

No wonder noobs get confused across the testing domains. Some great informative posts here relating to AVCT in amongst the dross

Bottom line is some people need to do more research and not rely on BB posts, which 90% are misleading and or factually incorrect

Im expecting a blue opening and £1 breach, as test stock are red hot and imminent AVCT news is expected